You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Merck declines after weak Q2 numbers

Capital Market 

fell 2.01% to Rs 1,228.58 at 9:51 on after net profit fell 11.6% to Rs 20.13 crore on 3.7% decrease in net sales to Rs 251.61 crore in Q2 June 2017 over Q2 June 2016.

The result was announced after market hours yesterday, 7 August 2017.

Meanwhile, the S&P Sensex was down 63.28 points, or 0.2% at 32,210.39. The S&P Small-Cap index was down 51.79 points, or 0.32% at 16,057.42.

On the BSE, 1,103 shares were traded on the counter so far as against the average daily volumes of 4,758 shares in the past one quarter. The stock had hit a high of Rs 1,252.90 and a low of Rs 1,201.70 so far during the day. The stock had hit a record high of Rs 1,320 on 27 July 2017 and a 52-week low of Rs 681 on 30 September 2016.

The stock had outperformed the market over the past one month till 7 Aug 2017, advancing 16.29% compared with the Sensex's 2.91% rise. The scrip had also outperformed the market over the past one quarter advancing 15.53% as against the Sensex's 8.09% rise. The scrip had also outperformed the market over the past one year advancing 79.06% as against the Sensex's 14.94% rise.

The small-cap company has equity capital of Rs 16.60 crore. Face value per share is Rs 10.

is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments: pharmaceuticals and chemicals.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, August 08 2017. 09:53 IST